Welcome to CardioSHIELD: Digital

CardioSHIELD: Digital is an interactive e-learning CPD activity focused on the exploration of actionable methods for enhancing the management of patients who are presently at an elevated risk of experiencing another cardiovascular (CV) event.

This website is intended for Australian healthcare professionals only.

CardioSHIELD: Digital is a 5 hr CPD approved activity in the RACGP 2023-2025 triennium which spans across all 3 of the Medical Board of Australia's categories.

PLEASE NOTE: CPD hours will be uploaded upon completion of the full activity, regardless of what year the activity was started in.

DID YOU KNOW?

Elevated cholesterol is a critical modifiable risk factor in cardiovascular disease1,2

ALMOST 1 IN 5 CVD PATIENTS experience another MI, stroke or CV death over the following year^3

^ A retrospective, cohort analysis of 108,315 patients admitted to a Swedish hospital due to MI

THERE IS SIGNIFICANT OPPORTUNITY TO REDUCE THIS IN AUSTRALIA1,2,4-6:

Nearly 1 in 2 (48%) high-risk patients with CVD in Australia
have LDL-C above the recommended secondary prevention target

After an event, nearly 1 in 2 (45%) patients in Australia do not meet
the recommended LDL-C target for secondary prevention within 12 months post hospital discharge following an acute coronary event‡5,6

Nearly 1 in 2 (45%) patients with CVD in Australia
is not on recommended intensive lipid-lowering therapy 12 months post hospital discharge following an acute coronary event‡5,6

An observational analysis of 107,664 high-risk patients with prior CVD attending Australian general practice participating in the Medicine Insight program from 2010-mid-2019 (average follow-up 5.3 y)2

CONCORDANCE: Retrospective cohort study of an Australian ACS registry, 2009-2018, of adults admitted with confirmed acute coronary syndrome of cardiovascular origin.4,5

MI = myocardial infarction; CV = cardiovascular; CVD = cardiovascular disease

References:

1. Carrington M, Cao T, Haregu T, et al. CODE RED: Overturning Australia’s cholesterol complacency. Melbourne: Baker Heart and Diabetes Institute; 2020. 2. Heart Foundation (Australia); World Heart foundation. REPORT: Cholesterol Roadblocks and Solutions: Tackling a Leading Risk Factor for CVD. A report form Australia’s National Roundtable on Cholesterol. 30 June 2022, Canberra. 3. Jernberg T, Basvold P, Henriksson M, et al. Eur Heart J 2015;36(19):1163–1170. 4. Murphy A, Faria-Netoy JR, Al- Rasadiz K, et al. Glob Heart 2017;12(3):179-197.e175. 5. Alsadat N, Hyun K, Boroumand F, et al. Med J Aust 2022;216(9):463-468. 6. Brieger D, D’Souza M, Karice Huyn K, et al. Med J Aust 2019;210(2):80-85